HIGH TIDE INC (HITI) Stock Fundamental Analysis
USA - NASDAQ:HITI - CA42981E4013 - Common Stock
3.57 USD
-0.14 (-3.77%)
3.6 USD
+0.03 (+0.84%)
HITI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 196 industry peers in the Pharmaceuticals industry. HITI scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. HITI is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
HITI had negative earnings in the past year.
HITI had a positive operating cash flow in the past year.
HITI had negative earnings in each of the past 5 years.
Of the past 5 years HITI 4 years had a positive operating cash flow.
1.2 Ratios
HITI has a Return On Assets of -3.76%. This is in the better half of the industry: HITI outperforms 73.47% of its industry peers.
The Return On Equity of HITI (-6.93%) is better than 76.53% of its industry peers.
HITI has a Return On Invested Capital of 5.06%. This is amongst the best in the industry. HITI outperforms 82.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROIC | 5.06% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a decent Operating Margin value of 2.30%, HITI is doing good in the industry, outperforming 78.57% of the companies in the same industry.
HITI's Gross Margin of 25.83% is in line compared to the rest of the industry. HITI outperforms 53.06% of its industry peers.
HITI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), HITI is destroying value.
Compared to 1 year ago, HITI has more shares outstanding
Compared to 5 years ago, HITI has more shares outstanding
Compared to 1 year ago, HITI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 3.60 indicates that HITI is not in any danger for bankruptcy at the moment.
HITI's Altman-Z score of 3.60 is fine compared to the rest of the industry. HITI outperforms 75.51% of its industry peers.
HITI has a debt to FCF ratio of 4.08. This is a neutral value as HITI would need 4.08 years to pay back of all of its debts.
HITI has a Debt to FCF ratio of 4.08. This is amongst the best in the industry. HITI outperforms 86.22% of its industry peers.
HITI has a Debt/Equity ratio of 0.43. This is a healthy value indicating a solid balance between debt and equity.
HITI's Debt to Equity ratio of 0.43 is in line compared to the rest of the industry. HITI outperforms 41.84% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Altman-Z | 3.6 |
ROIC/WACC0.56
WACC9.09%
2.3 Liquidity
HITI has a Current Ratio of 1.85. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
HITI has a worse Current ratio (1.85) than 61.73% of its industry peers.
HITI has a Quick Ratio of 1.29. This is a normal value and indicates that HITI is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.29, HITI is not doing good in the industry: 66.84% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 |
3. Growth
3.1 Past
The earnings per share for HITI have decreased strongly by -321.45% in the last year.
Looking at the last year, HITI shows a quite strong growth in Revenue. The Revenue has grown by 11.18% in the last year.
The Revenue has been growing by 75.59% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-321.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.71%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.9%
3.2 Future
The Earnings Per Share is expected to grow by 74.44% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 14.96% on average over the next years. This is quite good.
EPS Next Y-6.88%
EPS Next 2Y83.38%
EPS Next 3Y93.9%
EPS Next 5Y74.44%
Revenue Next Year11.85%
Revenue Next 2Y16.73%
Revenue Next 3Y17.75%
Revenue Next 5Y14.96%
3.3 Evolution
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. Valuation
4.1 Price/Earnings Ratio
HITI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
With a Price/Forward Earnings ratio of 57.20, HITI can be considered very expensive at the moment.
HITI's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. HITI is cheaper than 68.88% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.70, HITI is valued quite expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 57.2 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, HITI is valued cheaper than 85.71% of the companies in the same industry.
84.18% of the companies in the same industry are more expensive than HITI, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 21.71 | ||
| EV/EBITDA | 12.25 |
4.3 Compensation for Growth
HITI's earnings are expected to grow with 93.90% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y83.38%
EPS Next 3Y93.9%
5. Dividend
5.1 Amount
No dividends for HITI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
3.57
-0.14 (-3.77%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)
Earnings (Next)
Inst Owners7.98%
Inst Owner Change-4.1%
Ins Owners8.81%
Ins Owner ChangeN/A
Market Cap310.88M
Analysts80
Price Target5.67 (58.82%)
Short Float %5.3%
Short Ratio5.64
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)250.72%
Min EPS beat(2)-8%
Max EPS beat(2)509.45%
EPS beat(4)1
Avg EPS beat(4)43.58%
Min EPS beat(4)-315.76%
Max EPS beat(4)509.45%
EPS beat(8)5
Avg EPS beat(8)89.17%
EPS beat(12)9
Avg EPS beat(12)71.28%
EPS beat(16)12
Avg EPS beat(16)52.88%
Revenue beat(2)1
Avg Revenue beat(2)-0.1%
Min Revenue beat(2)-1.49%
Max Revenue beat(2)1.3%
Revenue beat(4)3
Avg Revenue beat(4)0.64%
Min Revenue beat(4)-1.49%
Max Revenue beat(4)1.6%
Revenue beat(8)5
Avg Revenue beat(8)0.05%
Revenue beat(12)9
Avg Revenue beat(12)1.51%
Revenue beat(16)13
Avg Revenue beat(16)7.42%
PT rev (1m)1.12%
PT rev (3m)11.41%
EPS NQ rev (1m)80.02%
EPS NQ rev (3m)85.73%
EPS NY rev (1m)-21.22%
EPS NY rev (3m)-21.22%
Revenue NQ rev (1m)-0.52%
Revenue NQ rev (3m)0.11%
Revenue NY rev (1m)0.62%
Revenue NY rev (3m)-0.13%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | 57.2 | ||
| P/S | 0.75 | ||
| P/FCF | 21.71 | ||
| P/OCF | 14.62 | ||
| P/B | 3.02 | ||
| P/tB | 8.23 | ||
| EV/EBITDA | 12.25 |
EPS(TTM)-0.09
EYN/A
EPS(NY)0.06
Fwd EY1.75%
FCF(TTM)0.16
FCFY4.61%
OCF(TTM)0.24
OCFY6.84%
SpS4.74
BVpS1.18
TBVpS0.43
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -3.76% | ||
| ROE | -6.93% | ||
| ROCE | 6.4% | ||
| ROIC | 5.06% | ||
| ROICexc | 7.36% | ||
| ROICexgc | 20.27% | ||
| OM | 2.3% | ||
| PM (TTM) | N/A | ||
| GM | 25.83% | ||
| FCFM | 3.47% |
ROA(3y)-14.91%
ROA(5y)-13.84%
ROE(3y)-26.27%
ROE(5y)-34.31%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-8.25%
GM growth 5Y-5.48%
F-Score5
Asset Turnover2.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.43 | ||
| Debt/FCF | 4.08 | ||
| Debt/EBITDA | 1.67 | ||
| Cap/Depr | 41.17% | ||
| Cap/Sales | 1.68% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 80.65% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.85 | ||
| Quick Ratio | 1.29 | ||
| Altman-Z | 3.6 |
F-Score5
WACC9.09%
ROIC/WACC0.56
Cap/Depr(3y)28.99%
Cap/Depr(5y)34.63%
Cap/Sales(3y)1.88%
Cap/Sales(5y)2.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-321.45%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%37.71%
EPS Next Y-6.88%
EPS Next 2Y83.38%
EPS Next 3Y93.9%
EPS Next 5Y74.44%
Revenue 1Y (TTM)11.18%
Revenue growth 3Y42.34%
Revenue growth 5Y75.59%
Sales Q2Q%13.9%
Revenue Next Year11.85%
Revenue Next 2Y16.73%
Revenue Next 3Y17.75%
Revenue Next 5Y14.96%
EBIT growth 1Y2.97%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year316.17%
EBIT Next 3Y105.72%
EBIT Next 5Y77.23%
FCF growth 1Y38%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y51.53%
OCF growth 3YN/A
OCF growth 5YN/A